Humanscape Technology Co., Ltd.

Humanscape Technology Co. , Ltd. is a digital health company focused on enhancing patient engagement and healthcare management through innovative technology solutions. Founded in 2016, Humanscape Technology Co.

, Ltd. is based in Seoul, South Korea, and specializes in digital health solutions. The company has executed a total of 13 deals, with its most recent funding round being a pre-IPO in December 2025, raising KRW 5 billion from new investor Naver, with participation from existing investors Korea Investment Partners Southeast Asia and Daewoong Investment. The CEO is Jun Lee, and co-founders include Stephen Chang and Yong Yong.

Humanscape Technology Co. , Ltd. 's core product offerings center around digital health solutions designed to improve patient engagement and streamline healthcare processes. The company provides a platform that connects patients with healthcare providers, aiming to enhance the management of chronic diseases and facilitate more effective communication within the healthcare ecosystem.

The services include patient education, remote monitoring, and data analytics, addressing the needs of patients who require ongoing support and management for their conditions. The target client base comprises healthcare providers, pharmaceutical companies, and patients, with key geographical markets spanning South Korea, Indonesia, the United States, and Vietnam. By integrating technology into health management, Humanscape Technology Co. , Ltd.

seeks to resolve challenges related to patient adherence, access to information, and care coordination. Humanscape Technology Co. , Ltd. generates revenue through a combination of subscription models and partnerships with healthcare organizations and pharmaceutical companies.

Clients typically engage with the platform on a subscription basis, allowing healthcare providers to access comprehensive patient data analytics and engagement tools. Additionally, the company collaborates with pharmaceutical firms to create tailored solutions that enhance patient outreach and support programs for specific medications or therapies. These transactions are structured to provide significant value to both healthcare providers and patients, ensuring that the services offered align with the needs of the market. While specific pricing plans for individual services have not been disclosed, the company positions its offerings to cater to varying scales of healthcare operations, from small clinics to large hospital networks.

In December 2025, Humanscape Technology Co. , Ltd. raised KRW 5 billion in pre-IPO funding, which will be utilized to venture into the international market particularly the US, and improve its artificial intelligence-based healthcare technology.